Plasma viscosity in giant cell arteritis as a predictor of disease activity

M Gudmundsson1, E Nordborg, B A Bengtsson

  • 1Department of Rheumatology, Sahlgren University Hospital, Gothenburg University, Sweden.

Insights

Plasma viscosity is a superior marker to erythrocyte sedimentation rate (ESR) for monitoring giant cell arteritis (GCA) treatment and predicting disease flares. This study highlights its clinical utility in managing GCA patients on prednisolone.

Area of Science:

  • Rheumatology
  • Clinical Immunology
  • Internal Medicine

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis requiring long-term management.
  • Standardized prednisolone treatment is common for GCA.
  • Monitoring disease activity and predicting flares are crucial for effective GCA management.

Purpose of the Study:

  • To compare plasma viscosity, ESR, CRP, and fibrinogen in GCA patients.
  • To evaluate the utility of these markers in predicting flare-ups.
  • To assess the effectiveness of plasma viscosity in clinical monitoring of GCA treatment.

Main Methods:

  • Follow-up of 31 GCA patients on prednisolone for one year.
  • Analysis of plasma viscosity, ESR, CRP, and fibrinogen levels.
  • Correlation of laboratory variables with clinical findings and disease flares.

Main Results:

  • All patients showed elevated plasma viscosity and ESR at diagnosis.
  • CRP normalized faster than ESR, plasma viscosity, and fibrinogen.
  • Plasma viscosity and ESR correlated closely with clinical findings and predicted flares.
  • Plasma viscosity demonstrated advantages over ESR in predicting flares and monitoring treatment.

Conclusions:

  • Plasma viscosity is a valuable tool for monitoring GCA activity.
  • Plasma viscosity offers superior predictive capabilities for flare-ups compared to ESR.
  • Plasma viscosity aids in the clinical management of GCA patients receiving glucocorticoids.

Related Concept Videos